Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

603229.SS Gross Margin

The Gross Margin of Zhejiang Ausun Pharmaceutical Co Ltd (603229.SS) is 51.04%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

603229.SS Gross Margin - Historical Value
Date Value
2025-12-31 51.04%
2024-12-31 53.05%
2023-12-31 54.40%
2022-12-31 51.27%
2021-12-31 54.14%
2020-12-31 55.38%
2019-12-31 49.14%
2018-12-31 43.58%
2017-12-31 59.03%
2016-12-31 55.03%
603229.SS Gross Margin - Peers Comparison
Ticker Name Value
300436.SZ Fujian Cosunter Pharmaceutical Co Ltd 53.90%
300765.SZ CSPC Innovation Pharmaceutical Co Ltd 38.22%
603566.SS Pulike Biological Engineering Inc 59.80%
002287.SZ Tibet Cheezheng Tibetan Medicine Co Ltd 83.00%
603439.SS Guizhou Sanli Pharmaceutical Co Ltd 69.41%
688505.SS Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 89.67%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 74.92%
600851.SS Shanghai Haixin Group Co Ltd 46.37%
603718.SS Shanghai Hile Bio-Technology Co Ltd 72.34%
605116.SS Aurisco Pharmaceutical Co Ltd 58.92%
688356.SS Jenkem Technology Co Ltd 58.12%
300401.SZ Zhejiang Garden Biopharmaceutical Co Ltd 55.25%
300497.SZ Jiangxi Fushine Pharmaceutical Co Ltd 16.11%
300573.SZ Shenyang Xingqi Pharmaceutical Co Ltd 80.67%
300723.SZ ApicHope Pharmaceutical Group Co Ltd 55.39%
300871.SZ Wuhan Hvsen Biotechnology Co Ltd 30.86%
002275.SZ Guilin Sanjin Pharmaceutical Co Ltd 75.14%
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 72.71%
603222.SS Chimin Health Management Co Ltd 24.10%
603669.SS Lionco Pharmaceutical Group Co Ltd 42.75%
688189.SS Hunan Nucien Pharmaceutical Co Ltd 26.63%
1477.HK Ocumension Therapeutics 44.87%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 89.92%
603811.SS Zhejiang Cheng Yi Pharmaceutical Co Ltd 68.88%
605199.SS Hainan Huluwa Pharmaceutical Group Co Ltd 27.16%
688098.SS Shanghai Shen Lian Biomedical Corp 56.82%
002907.SZ Chongqing Pharscin Pharmaceutical Co Ltd 57.21%
300199.SZ Hybio Pharmaceutical Co Ltd 56.41%